Princeton, N.J. (April 30, 2009) – Novo Nordisk, a world leader in diabetes care, has been recognized as the “Best Place to Work in New Jersey” by NJBiz, the state’s largest weekly business newspaper. This is the third time in five years the company has achieved this honor. Earlier this year, the company was recognized as one of FORTUNE’s “100 Best Companies to Work For.”
“This award is a tribute to our unique company culture and our commitment to inspire and engage our employees through our company’s vision of defeating diabetes” said Jerzy Gruhn, president of Novo Nordisk Inc. “You can attract top talent with compensation and benefits, but you retain them through a sense of purpose and a common passion. Ours is working for the people who need our therapies.”
The ranking is based on an independent assessment of policies, practices and demographics as well as a comprehensive employee survey.
“Our continued presence and high ranking on the list demonstrates the value we place on the personal and professional satisfaction and growth of our employees,” said Jeff Frazier, vice president of human resources. “To maintain and extend Novo Nordisk’s competitive advantage, we apply innovative thinking to better our organizational structure, provide responsible employee health incentives and offer exciting developmental opportunities that resonate with our employees.”
Among the company attributes considered in Novo Nordisk’s recognition is the company’s creative benefits program for employees in a variety of areas. This year, Novo Nordisk developed and implemented College Coach, a program that assists parents with preparing for college savings. Other company efforts include concierge services, backup care for children and dependent adults, and a generous 401k plan: Novo Nordisk contributes 8 percent to an employee’s 401k even if that individual does not participate.
In addition to finding professional gratification, Novo Nordisk employees report an emotional connection with the company’s goals. In the most recent annual survey employees rated an average score of 4.68 out of a possible five to indicate their level of agreement with statements including “Novo Nordisk is leading the fight against diabetes,” “Novo Nordisk’s results within the social and environmental area are important to the future of the company,” and “I am proud of our products.”
The “Best Place to Work in New Jersey” award is part of the weekly publication’s annual survey to honor the companies in New Jersey that show a dedication to their employees’ growth and quality of life, which was published in a supplement to the April 27 issue and online at www.njbiz.com.
About Novo Nordisk
Novo Nordisk is a healthcare company with an 86-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk’s business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. With headquarters in Denmark, Novo Nordisk employs more than 27,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol ‘NVO’. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.
